10 November 2015

Ellex to Host ABiC Symposium at AAO 2015 Meeting

Adelaide, Australia, 10 November 2015 – Ellex Medical Lasers Ltd will host a breakfast symposium featuring experts in Ab-Interno Canaloplasty (ABiC) at the 2015 meeting of the American Academy of Ophthalmology (AAO) being held in Las Vegas, USA from November 14-17.

The symposium, which will be held on Monday, November 16 at The Mirage, Grand Ballroom ‘G’, from 7:00 am – 8:00 am will feature presentations from glaucoma surgeons, Mahmoud A. Khaimi, MD, Dean McGee Eye Institute, University of Oklahoma, USA, and Mark J. Gallardo, MD, El Paso Eye Surgeons, Texas, USA, both of whom have wide experience with Canaloplasty.

A modification of traditional Canaloplasty, Ab-interno Canaloplasty (ABiC) is a novel minimally-invasive glaucoma treatment that conserves the clinically proven benefits of 360o viscodilation of Schlemm’s canal through a clear corneal incision, but does not require a tensioning suture. The rationale for ABiC is based on data from early clinical trials which showed that those patients who did not successfully receive a tensioning suture had a reduction in intraocular pressure (IOP) of 10 mmHg on one medication at three years

In a case series study of 70 patients undertaken by Dr Gallardo, preliminary findings showed that mean IOP was reduced from 20.3±5.8 mmHg preoperatively to 13.0±3.6 at 3 months post-ABiC and to 12.3±3.8 at 6 months post-ABiC. Additionally, the mean number of medications was reduced from 2.4±0.9 to 0.5±0.9 and 0.5±1.0 at 3 months and 6 months, respectively.

“ABiC not only follows the strong science behind traditional Canaloplasty and the safety-first premise of minimally-invasive glaucoma surgery (MIGS), it also comprehensively addresses all aspects of outflow resistance, i.e., the trabecular meshwork, Schlemm’s canal, and collector channel distal outflow. ” says Dr Gallardo.

“In fact ABiC is the only MIGS procedure that addresses the collector channels. It also preserves the conjunctiva and angle structures, thereby further enhancing aqueous outflow, and can be performed before, in conjunction with, or after cataract extraction”, he adds.

Ellex is also hosting Meet the Expert sessions at the Ellex Exhibit (#3755) on Saturday, November 14 and Sunday, November 15, where Dr Khaimi and Dr
Gallardo will share their pearls for success with ABiC. Dr Gallardo will be available on Saturday, November 14 from 12:15 – 12:30 pm and 3:15 – 3:30pm, and on Sunday, November 15 from 2:15 – 2:30 pm. Dr Khaimi will be in attendance on Sunday, November 15 from 11:00 – 11:15 am, 12:15 – 12:30 pm, 2:00 – 2:15 pm and 3:00 – 3:15 pm.


Ellex Medical (Ellex) is a pioneer in the development of medical technologies for the diagnosis and treatment of eye disease. With more than 20,000 systems delivered to market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan, France, Germany and Australia, and a network of distribution partners in more than 100 countries. In recent years, Ellex has diversified its product range beyond lasers and ultrasound equipment to include distribution of a number of complementary third-party ophthalmic products. On 31 December 2013 Ellex acquired the Canaloplasty microcatheterbased glaucoma surgical treatment from iScience Interventional, Inc.

For additional information about Ellex and its products, please visit www.ellex.com

Ellex to Host ABiC Symposium at AAO 2015 Meeting